Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 5.96
(1.19%)
CNY 5.96
(1.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 663.62 Million CNY | -10.03% |
| 2022 | 737.56 Million CNY | -7.18% |
| 2021 | 794.62 Million CNY | 7.1% |
| 2020 | 741.94 Million CNY | 10.98% |
| 2019 | 668.53 Million CNY | -3.9% |
| 2018 | 695.66 Million CNY | -11.06% |
| 2017 | 782.15 Million CNY | 51.67% |
| 2016 | 515.69 Million CNY | 1.34% |
| 2015 | 508.87 Million CNY | 114.42% |
| 2014 | 237.32 Million CNY | 115.02% |
| 2013 | 110.37 Million CNY | 40.42% |
| 2012 | 78.6 Million CNY | 14.8% |
| 2011 | 68.47 Million CNY | 16.66% |
| 2010 | 58.69 Million CNY | -37.77% |
| 2009 | 94.3 Million CNY | 49.8% |
| 2008 | 62.95 Million CNY | 303.2% |
| 2007 | 15.61 Million CNY | -24.27% |
| 2006 | 20.61 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 666.88 Million CNY | 0.49% |
| 2024 Q2 | 532.94 Million CNY | -20.08% |
| 2024 Q3 | 613.06 Million CNY | 15.03% |
| 2023 Q3 | 646.62 Million CNY | -4.34% |
| 2023 Q4 | 663.62 Million CNY | 2.63% |
| 2023 Q2 | 675.93 Million CNY | -8.77% |
| 2023 Q1 | 740.9 Million CNY | 0.45% |
| 2023 FY | 663.62 Million CNY | -10.03% |
| 2022 Q1 | 795.6 Million CNY | 0.12% |
| 2022 Q3 | 700.05 Million CNY | 2.01% |
| 2022 Q4 | 737.56 Million CNY | 5.36% |
| 2022 FY | 737.56 Million CNY | -7.18% |
| 2022 Q2 | 686.25 Million CNY | -13.74% |
| 2021 Q2 | 687.8 Million CNY | -14.72% |
| 2021 Q3 | 693.84 Million CNY | 0.88% |
| 2021 FY | 794.62 Million CNY | 7.1% |
| 2021 Q1 | 806.48 Million CNY | 8.7% |
| 2021 Q4 | 794.62 Million CNY | 14.53% |
| 2020 Q2 | 657.61 Million CNY | -2.83% |
| 2020 Q4 | 741.94 Million CNY | 10.02% |
| 2020 Q3 | 674.34 Million CNY | 2.54% |
| 2020 FY | 741.94 Million CNY | 10.98% |
| 2020 Q1 | 676.73 Million CNY | 1.23% |
| 2019 Q4 | 668.53 Million CNY | -3.69% |
| 2019 FY | 668.53 Million CNY | -3.9% |
| 2019 Q1 | 646.33 Million CNY | -7.09% |
| 2019 Q2 | 689.12 Million CNY | 6.62% |
| 2019 Q3 | 694.17 Million CNY | 0.73% |
| 2018 FY | 695.66 Million CNY | -11.06% |
| 2018 Q4 | 695.66 Million CNY | -3.08% |
| 2018 Q3 | 717.8 Million CNY | -0.12% |
| 2018 Q2 | 718.66 Million CNY | 1.04% |
| 2018 Q1 | 711.26 Million CNY | -9.06% |
| 2017 Q1 | 615.43 Million CNY | 19.34% |
| 2017 FY | 782.15 Million CNY | 51.67% |
| 2017 Q4 | 782.15 Million CNY | -1.3% |
| 2017 Q3 | 792.44 Million CNY | -2.73% |
| 2017 Q2 | 814.67 Million CNY | 32.37% |
| 2016 Q3 | 501.66 Million CNY | 5.85% |
| 2016 Q2 | 473.96 Million CNY | 11.95% |
| 2016 Q1 | 423.36 Million CNY | -16.8% |
| 2016 FY | 515.69 Million CNY | 1.34% |
| 2016 Q4 | 515.69 Million CNY | 2.8% |
| 2015 Q4 | 508.87 Million CNY | 37.73% |
| 2015 Q1 | 290.68 Million CNY | 22.48% |
| 2015 FY | 508.87 Million CNY | 114.42% |
| 2015 Q3 | 369.47 Million CNY | 12.58% |
| 2015 Q2 | 328.19 Million CNY | 12.91% |
| 2014 FY | 237.32 Million CNY | 115.02% |
| 2014 Q4 | 237.32 Million CNY | 20.9% |
| 2014 Q3 | 196.3 Million CNY | 32.96% |
| 2014 Q2 | 147.64 Million CNY | 53.58% |
| 2014 Q1 | 96.13 Million CNY | -12.9% |
| 2013 Q4 | 110.37 Million CNY | 5.93% |
| 2013 FY | 110.37 Million CNY | 40.42% |
| 2013 Q1 | 68.09 Million CNY | -13.37% |
| 2013 Q2 | 75.16 Million CNY | 10.39% |
| 2013 Q3 | 104.19 Million CNY | 38.61% |
| 2012 Q1 | 58.87 Million CNY | -14.01% |
| 2012 Q2 | 62.69 Million CNY | 6.49% |
| 2012 Q4 | 78.6 Million CNY | 8.18% |
| 2012 FY | 78.6 Million CNY | 14.8% |
| 2012 Q3 | 72.65 Million CNY | 15.89% |
| 2011 Q2 | 60.38 Million CNY | 21.91% |
| 2011 FY | 68.47 Million CNY | 16.66% |
| 2011 Q4 | 68.47 Million CNY | 9.75% |
| 2011 Q1 | 49.52 Million CNY | -15.61% |
| 2011 Q3 | 62.38 Million CNY | 3.32% |
| 2010 Q3 | 68.92 Million CNY | 24.7% |
| 2010 Q2 | 55.27 Million CNY | 0.2% |
| 2010 Q1 | 55.16 Million CNY | -41.51% |
| 2010 FY | 58.69 Million CNY | -37.77% |
| 2010 Q4 | 58.69 Million CNY | -14.85% |
| 2009 Q2 | 81.06 Million CNY | 0.0% |
| 2009 Q3 | 85.89 Million CNY | 5.96% |
| 2009 Q4 | 94.3 Million CNY | 9.8% |
| 2009 FY | 94.3 Million CNY | 49.8% |
| 2008 Q4 | 62.95 Million CNY | 0.0% |
| 2008 FY | 62.95 Million CNY | 303.2% |
| 2007 FY | 15.61 Million CNY | -24.27% |
| 2006 FY | 20.61 Million CNY | 0.0% |